KPW
Kore Private Wealth Portfolio holdings
AUM
$554M
1-Year Return
17.38%
This Quarter Return
+28.89%
1 Year Return
-17.38%
3 Year Return
+35.61%
5 Year Return
–
10 Year Return
–
AUM
$490M
AUM Growth
+$71.5M
(+17%)
Cap. Flow
-$23.9M
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
35.86%
Holding
1,338
New
225
Increased
320
Reduced
324
Closed
102
Top Buys
| 1 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$8.62M |
| 2 |
Blue Owl Capital
OBDC
|
+$5.11M |
| 3 |
Applied Therapeutics
APLT
|
+$4.52M |
| 4 |
Pinterest
PINS
|
+$4.1M |
| 5 |
Uber
UBER
|
+$3.23M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$13.8M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$7.37M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.18M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.36M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$2.49M |
Sector Composition
| 1 | Technology | 15.05% |
| 2 | Energy | 10.08% |
| 3 | Communication Services | 6.31% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Financials | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLLS
651
Cellectis
CLLS
$306M
| $19K | ﹤0.01% |
+1,097
| New | +$19K |
|
652
CRISPR Therapeutics
CRSP
$4.71B
| $19K | ﹤0.01% |
+268
| New | +$19K |
|
653
KalVista Pharmaceuticals
KALV
$775M
| $19K | ﹤0.01% |
+1,605
| New | +$19K |
|
654
KLA
KLAC
$123B
| $19K | ﹤0.01% |
98
-108
| -52% | -$20.9K |
|
655
MidCap Financial Investment
MFIC
$1.17B
| $19K | ﹤0.01% |
2,066
| – | – |
|
656
Pool Corp
POOL
$11.9B
| $19K | ﹤0.01% |
+72
| New | +$19K |
|
657
Ultragenyx Pharmaceutical
RARE
$3.02B
| $19K | ﹤0.01% |
250
| – | – |
|
658
Vornado Realty Trust
VNO
$7.77B
| $19K | ﹤0.01% |
518
-2,670
| -84% | -$97.9K |
|
659
Whirlpool
WHR
$5.24B
| $19K | ﹤0.01% |
152
+149
| +4,967% | +$18.6K |
|
660
Xylem
XYL
$33.5B
| $19K | ﹤0.01% |
298
-99
| -25% | -$6.31K |
|
|
BERY
661
DELISTED
Berry Global Group, Inc.
BERY
| $19K | ﹤0.01% |
+476
| New | +$19K |
|
662
Bank of Montreal
BMO
$90.5B
| $18K | ﹤0.01% |
353
+273
| +341% | +$13.9K |
|
663
Beyond Meat
BYND
$191M
| $18K | ﹤0.01% |
135
-2,670
| -95% | -$356K |
|
664
CBRE Group
CBRE
$48.4B
| $18K | ﹤0.01% |
399
-352
| -47% | -$15.9K |
|
665
Civeo
CVEO
$291M
| $18K | ﹤0.01% |
+2,541
| New | +$18K |
|
666
iShares MSCI KLD 400 Social ETF
DSI
$4.85B
| $18K | ﹤0.01% |
314
| – | – |
|
667
FedEx
FDX
$53.3B
| $18K | ﹤0.01% |
134
| – | – |
|
668
Goldman Sachs BDC
GSBD
$1.29B
| $18K | ﹤0.01% |
1,135
| – | – |
|
669
Healthcare Services Group
HCSG
$1.14B
| $18K | ﹤0.01% |
755
| – | – |
|
670
Kraft Heinz
KHC
$31.5B
| $18K | ﹤0.01% |
579
| – | – |
|
671
SLR Investment Corp
SLRC
$907M
| $18K | ﹤0.01% |
1,140
| – | – |
|
672
ScottsMiracle-Gro
SMG
$3.5B
| $18K | ﹤0.01% |
+134
| New | +$18K |
|
673
Steris
STE
$24B
| $18K | ﹤0.01% |
120
+50
| +71% | +$7.5K |
|
674
Toronto Dominion Bank
TD
$130B
| $18K | ﹤0.01% |
424
-1,023
| -71% | -$43.4K |
|
675
Global X Uranium ETF
URA
$4.31B
| $18K | ﹤0.01% |
1,750
| – | – |
|